Boult Wade Tennant
Bulletins » Interim declaration unavailable on queries of patent infringement

In cases of UK patent infringement, the courts may grant a variety of remedies to successful claimants (including damages, court-ordered injunctions, and declarations of non-infringement). In some cases, remedies are also available on an interim basis – for example, an interim injunction that requires a party to refrain from an allegedly infringing act pending outcome at trial.

In the recent decision, Shenzhen Carku Technology Co, Ltd v The Noco Company [2020] EWHC 2104, the High Court of England and Wales considered and refused a request for an interim declaration. In this case, the claimant requested an interim declaration of non-infringement of the defendant’s patent.

The decision
The claimant, Shenzhen Carku Technology Co, is a designer and manufacturer of car battery jump starts. The defendant, The NOCO Company, owns a patent for a portable vehicle battery jump start apparatus. NOCO complained to the online retailer Amazon about Carku’s listed products, as they believed their patent was being infringed by those products. Amazon took down some of Carku’s products, but offered to consider relisting them if they provided a “judicial decision” declaring non-infringement of the patent.

In court, Carku requested a summary judgement on their request for a declaration of non-infringement and, in the alternative, they requested an interim declaration of non-infringement to persuade Amazon to re-list their products.

The Judge acknowledged that interim declarations (which were developed as an alternative to interim injunctions) can be granted by the court in any proceedings. However, the Judge expressed doubt on whether such a remedy is available in the context of patent non-infringement.

In particular, the Judge considered a “clear and consistent line of case law” establishing that interim declarations are not appropriate or, at the very least, difficult to get in respect of questions that only permit of a final answer. The Judge further concluded that patent infringement is such a question, stating:

“…it seems to me that despite the claimant’s attempts to persuade me to the contrary, infringement is indeed a yes/no question, and it only permits a final answer, not a temporary one. The products either infringe or they do not. It would not be satisfactory to grant a declaration one day which might become false another day. That is because it cannot be right to say that certain acts infringe a patent one day but the same acts do not infringe the same patent another day. It is not as if there is any interim state of affairs which is subject to change.”

In addition to the above, the judge found no evidence that an interim declaration would actually solve Carku’s issue in this case. Rather, the judge believed it was most likely that Amazon would wait for a final ruling on infringement anyway, so an interim declaration would serve no useful purpose. The interim declaration was thus refused.

Conclusions
Based on the reasoning and case law set out in the decision, interim declarations do not seem to be an appropriate remedy in the yes/no question of patent infringement, particularly not with the aim of reversing a de-listing of products on online distribution platforms. It would appear parties seeking to re-list their products would need to await a final judgement regarding patent infringement.

Relevant sectors
Aerospace
  • Commercial aviation
  • Defence and security
  • Space and satellites
  • Unmanned aerial vehicles
Artificial Intelligence and Machine Learning
Automotive
  • Autonomous vehicles
  • Electric vehicles
  • Engines
Biotechnology
  • Antibody engineering
  • Antibody manufacture and formulation
  • Bioinformatics
  • Biosimilars
  • Drug delivery
  • Gene editing (e.g. CRISPR)
  • Genomic and molecular tools and methods
  • GM crops
  • Immuno-oncology (e.g. checkpoint inhibitors; modified T cells)
  • Next generation sequencing
  • Nucleic acid synthesis
  • Personalised medicine/disease biomarkers
  • Recombinant protein production and purification
  • Stem cell therapies
  • Supplementary protection certificates (SPCs)
  • Synthetic biology
  • Therapeutic antibodies
  • Vaccinology (e.g. viral vectors; mRNA vaccines)
  • Women’s health products
Chemicals
  • Agrochemicals
  • Catalysts
  • Dispersions and colloids
  • Lubricants
  • Polymers and plastics
Communications and Networks
  • Cloud computing
  • Internet of things (IOT)
  • Oceanography, marine
  • Wired and wireless networks
Computing and Software
  • Artificial intelligence and machine learning
  • Bioinformatics
  • Blockchain and distributed ledgers
  • Communications and networks
  • Computer games
  • Data and software security, cryptography and digital rights management (DRM)
  • Data management and storage, databases and data compression
  • Digital assistants, virtual assistants and software agents
  • Fintech and adtech
  • Machine vision
  • Metaverse, virtual reality (VR) and augmented reality (AR)
  • Motor capture
  • Multimedia, audio/video processing and animation
  • Natural language processing
  • Quantum computing
  • Robotic process automation
  • Search engines
  • Signal processing
  • Software applications and systems, mobile applications, user interfaces
Consumer Goods and Retail
  • Anti-counterfeit devices
  • Beauty
  • Fashion
  • Health, fitness and sport
  • Household goods
  • Luxury goods
  • Moda
  • Retail
Electronics and Electrical Devices
  • Computer and IT architecture and system design
  • Medical devices
  • Optics
  • Restaurants and bars
  • Robotics
  • Scientific instruments
  • Semiconductor devices
  • Testing systems, control systems, signal processing
  • Travel and leisure
  • Wearable tech and human interfaces
Energy and Green Technologies
  • Biofuels
  • Clean air
  • Fuel cells and battery technology
  • Renewables and recycling
  • Solar power
  • Water, oil and gas, nuclear, fusion, fission
  • Wind turbines
Food and Beverage
  • Beverages
  • Nutrition
  • Retail
Industrial Manufacturing and Processing
  • Packaging
  • Polymers and plastics
  • Printing tech
  • Additive manufacturing
  • Coatings
  • Construction
Materials
  • Advanced materials
  • Composite materials
  • Metallurgy and alloys
  • Nanotechnology
Medical Devices and Diagnostics
  • Artificial intelligence
  • Devices
  • Diagnostic instruments
  • Digital health
  • Drug delivery
  • Immuno-oncology
  • In vitro diagnostics
  • Medtech
Pharmaceuticals
  • Diagnostics
  • Drug delivery
  • Generic market entry
  • Medicinal chemistry
  • Methods of production and synthesis
  • Personalised medicine/disease biomarkers
  • Pharmaceutical formulations
  • Pharmaceuticalsceutical formulations
  • Polymorphs
  • Small molecule pharmaceuticals
  • Supplementary protection certificates (SPCs)
Trade Marks
  • Consumer goods
  • Cosmetics and perfumery
  • Financial services
  • Mechanical engineering
  • Mechanical products
  • Services
  • Telecommunications